hsa-mir-4279: Hsa-mir-4279 is a 16 nucleotides-long sequence that is unlikely to correspond to a real microRNA [PMC8201247]. It has been found to be expressed in urinary extracellular vesicles of diabetic patients with macroalbumin [PMC8527307]. Hsa-mir-4279 is one of the CoV-tar-miRNAs that target the 3ʹUTR of the PSMB8 mRNA [PMC8527307]. It has also been identified as one of the potential target miRNAs for the SOCS3 gene [PMC8527307]. Hsa-mir-4279 has been associated with diabetes and is considered as a potential predictive marker for hepatocellular carcinoma recurrence [PMC8527307] [PMC5770356]. In addition, hsa-mir-4279 has been included in a list of miRNAs predicted to target the 3ʹUTR of the viral genome in pancreatic cancer [PMC7962059]. However, it should be noted that hsa-mir-4279 is not included in another list of miRNAs excluded from further analysis in pancreatic cancer research [PMC8107736]. Overall, hsa-mir-4279 appears to have potential roles in diabetes, hepatocellular carcinoma recurrence, and pancreatic cancer.